The global cardiac amyloidosis treatment market is experiencing significant growth due to the increasing prevalence of this serious heart condition worldwide. Furthermore, advancements in diagnostic techniques and the development of novel therapies are driving market growth. The market is characterized by a fragmented landscape with several key pl